Oral L-arginine supplementation in cystic fibrosis patients: A placebo-controlled study

European Respiratory Journal

Volumn 25, Issue 1, 2005, Pages 62-68

  Grasemann, H ^a   Grasemann, C ^a   Kurtz, F ^a   Tietze Schillings, G ^a   Vester, U ^a   Ratjen, F ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cystic fibrosis; L arginine; Lung function; Nitric oxide

Indexed keywords

ARGININE; NITRIC OXIDE; PLACEBO;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DATA ANALYSIS; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SPUTUM LEVEL;

ADOLESCENT; ADULT; ARGININE; CROSS-OVER STUDIES; CYSTIC FIBROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NITRIC OXIDE; PILOT PROJECTS; PROBABILITY; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 13444292529     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00086104     Document Type: Article

References (31)

1. Grasemann H, Michler E, Wallot M, Ratjen F. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 1997; 24: 173-177.
2. Grasemann H, Ratjen F. Cystic fibrosis lung disease: the role of nitric oxide. Pediatr Pulmonol 1999; 28: 442-448.
3. Kelly TJ, Drumm ML. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 1998; 102: 1200-1207.
4. Meng QH, Springall DR, Bishop AE, et al. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol 1998; 184: 323-331.
5. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax 1993; 48: 1034-1043.
6. Högman M, Frostell CG, Hedenstrom H, Hedenstierna G. Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 1993; 148: 1474-1478.
7. Lundberg JO, Settergren G, Gelinder S, Lundberg JM, Alving K, Weitzberg E. Inhalation of nasally derived nitric oxide modulates pulmonary function in humans. Acta Physiol Scand 1996; 158: 343-347.
8. Mhanna MJ, Ferkol T, Martin RJ, et al. Nitric oxide deficiency contributes to impairment of airway relaxation in cystic fibrosis mice. Am J Respir Cell Mol Biol 2001; 24: 621-626.
9. Ho LP, Innes JA, Greening AP. Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis. Eur Respir J 1998; 12: 1290-1294.
10. Grasemann H, Lax H, Treseler JW, Colin AA. Dornase alpha and exhaled NO in cystic fibrosis. Pediatr Pulmonol 2004; 38: 379-385.
11. Grasemann H, Ioannidis I, Tomkiewicz RP, de Groot H, Rubin BK, Ratjen F. Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child 1998; 78: 49-53.
12. Texereau J, Marullo S, Hubert D, et al. Nitric oxide synthase 1 as a potential modifier gene of decline in lung function in patients with cystic fibrosis. Thorax 2004; 59: 156-158.
13. Ratjen F, Gärtig S, Wiesemann HG, Grasemann H. Effect of inhaled nitric oxide on pulmonary function in cystic fibrosis. Respir Med 1999; 93: 579-583.
14. Grasemann H, Gärtig SS, Wiesemann HG, Teschler H, Konietzko N, Ratjen F. Effect of L-arginine infusion on exhaled nitric oxide in ciliary dyskinesia syndrome and cystic fibrosis. Eur Respir J 1999; 13: 114-118.
15. Kharitonov SA, Lubec G, Lubec B, Hjelm M, Barnes PJ. L-arginine increases exhaled nitric oxide in normal human subjects. Clin Sci (Lond) 1995; 88: 135-139.
16. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents. Methods, reference values. Prog Respir Res 1987; 22: 1-220.
17. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Resp J 1993; 6: Suppl. 6, 5-40.
18. Baraldi E, de Jongste JC. Measurement of exhaled nitric oxide in children, 2001. Eur Respir J 2002; 20: 223-237.
19. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children - 1999. Am J Respir Crit Care Med 1999; 160: 2104-2117.
20. Grasemann H, Storm van's Gravesande K, Gärtig S, et al. Nasal nitric oxide levels are associated with a polymorphism in the neuronal nitric oxide synthase (NOS1) genes in cystic fibrosis patients. Nitric Oxide 2002; 6: 236-241.
21. Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996; 75: 319-322.
22. Wooldridge JL, Deutsch GH, Sontag MK, et al. NO pathway in CF and non-CF children. Pediatr Pulmonol 2004; 37: 338-350.
23. Gaston B, Ratjen F, Vaughan JW, et al. Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am J Respir Crit Care Med 2002; 165: 387-390.
24. Jaffé A, Slade G, Rae J, Laverty A. Exhaled nitric oxide increases following admission for intravenous antibiotics in children with cystic fibrosis. J Cystic Fibrosis 2003; 2: 143-147.
25. Lee J, Ryu H, Ferrante RJ, Morris SM Jr, Ratan RR. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc Natl Acad Sci USA 2003; 100: 4843-4848.
26. Meurs H, Maarsingh H, Zaagsma J. Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol Sci 2003; 24: 450-455.
27. Morris CR, Poljakovic M, Lavrisha L, Machado L, Kuypers FA, Morris SM Jr. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med 2004; 170: 148-153.
28. Di Maria GU, Spicuzza L, Mistretta A, Mazzarella G. Role of endogenous nitric oxide in asthma. Allergy 2000; 55: Suppl. 61, 31-35.
29. Grasemann H, Knauer N, Büscher R, Hübner K, Drazen JM, Ratjen F. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit Care Med 2000; 162: 2172-2176.
30. Grasemann H, Storm van's Gravesande K, Büscher R, et al. Endothelial nitric oxide synthase variants in cystic fibrosis lung disease. Am J Respir Crit Care Med 2003; 167: 390-394.
31. Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med 1995; 1: 370-373.